Latest Bisphosphonate Stories

2014-06-18 16:26:25

ROSEMONT, Ill., June 18, 2014 /PRNewswire-USNewswire/ -- A new position paper on Medication Related Osteonecrosis of the Jaw (MRONJ) released by the American Association of Oral and Maxillofacial Surgeons, expands the scope of the condition previously referred to as Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) and changes its name to reflect the antiresorptive (denosumab) and antiangiogenic therapies that have recently been associated with the condition....

2014-05-29 08:28:55

--Recently Revised Label for Marketed Calcitonin Products Has Helped Clarify the Regulatory Landscape in the U.S.-- PHILADELPHIA, May 29, 2014 /PRNewswire/ -- Tarsa Therapeutics, Inc. today announced that it raised $7 million to prepare for filing a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for Ostora, its oral calcitonin tablet for the treatment of postmenopausal osteoporosis. The financing is the second tranche of a Series B round Tarsa announced...

2014-05-27 16:25:20

-Files patents on markers- TEL AVIV, Israel, May 27, 2014 /PRNewswire/ -- BioLight Life Sciences Investments Ltd. (OTC: BLGTY, TASE: BOLT), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announced today that Micromedic Technologies (TASE: MCTC), BioLight's cancer diagnostic cluster company, has identified several new genetic markers with high potential to predict necrosis of the jawbone in multiple...

2014-05-26 12:23:04

PISA, Italy and HONG KONG, May 26, 2014 /PRNewswire/ -- Abiogen Pharma S.p.A. of Pisa Italy and Lee's Pharm jointly announced the agreement for License, Distribution and Supply for marketing of Attila(R) (Neridronic Acid) throughout China, Hong Kong, Macau and Taiwan. Under the term of the agreement, Abiogen Pharma S.p.A. granted Lee's Pharm an exclusive license and right for registering, importing, marketing, distributing and selling Attila(R) in the territory, for the two...

2014-03-21 12:23:56

DUBLIN, Mar. 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/z7tp9t/research_report ) has announced the addition of the "Concise Analysis of the Chinese Osteoporosis Drug Market" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Osteoporosis is a systemic bone disease, a common disease among middle and old-aged people. It is characterized by low bone mineral density and deterioration of bone...

2013-12-12 10:46:34

New report shows aging populations and urbanization will drive increase in osteoporosis and related fractures; health authorities must take action now to reduce future costs and disability A new report launched today by the International Osteoporosis Foundation (IOF) shows that osteoporosis is a serious problem throughout the Asia Pacific, with the number of fracture sufferers to rise dramatically in the coming decades. By 2050, more than half of the world's hip fractures will occur in...

2013-11-21 11:41:24

Bisphosphonates are a group of compounds that have become well-known and are extensively used as drugs for treating bone-related diseases, such as osteoporosis. New uses for bisphosphonates were discovered, as their ability to form physical gels in pure water was reported for the first time in a recent study performed in collaboration with the Universities of Jyväskylä and Eastern Finland. The gelation tendencies of four bisphosphonates were studied in detail under the baton of Academy...

2013-07-05 23:18:43

According to court documents, on July 1st, a US Federal judge denied Merck’s attempt to wipe out a $285,000 plaintiff verdict on Fosamax jaw deterioration. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Fosamax side effects. San Diego, CA (PRWEB) July 05, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently and...

Word of the Day
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'